inTEST (INTT) Competitors

Quanterix (NASDAQ:QTRX) and inTEST (NYSE:INTT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, community ranking, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Does the MarketBeat Community favor QTRX or INTT?

Quanterix received 261 more outperform votes than inTEST when rated by MarketBeat users. Likewise, 61.82% of users gave Quanterix an outperform vote while only 57.89% of users gave inTEST an outperform vote.

Company	Underperform	Outperform
Quanterix	Outperform Votes 272 61.82%	Underperform Votes 168 38.18%
inTEST	Outperform Votes 11 57.89%	Underperform Votes 8 42.11%

Which has preferable valuation & earnings, QTRX or INTT?

inTEST has lower revenue, but higher earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quanterix	$135.44M	1.87	-$28.35M	-$1.03	-6.34
inTEST	$130.69M	0.67	$9.34M	$0.23	30.65

Is QTRX or INTT more profitable?

inTEST has a net margin of 2.33% compared to Quanterix's net margin of -30.12%. inTEST's return on equity of 5.31% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quanterix	-30.12%	-11.74%	-9.66%
inTEST	2.33%	5.31%	3.42%

Does the media favor QTRX or INTT?

In the previous week, Quanterix had 9 more articles in the media than inTEST. MarketBeat recorded 12 mentions for Quanterix and 3 mentions for inTEST. inTEST's average media sentiment score of 0.86 beat Quanterix's score of 0.51 indicating that inTEST is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quanterix	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
inTEST	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend QTRX or INTT?

Quanterix presently has a consensus target price of $18.25, indicating a potential upside of 179.27%. inTEST has a consensus target price of $16.00, indicating a potential upside of 126.95%. Given Quanterix's higher probable upside, analysts plainly believe Quanterix is more favorable than inTEST.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quanterix	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
inTEST	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Which has more risk & volatility, QTRX or INTT?

Quanterix has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, inTEST has a beta of 1.9, indicating that its share price is 90% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of QTRX or INTT?

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 63.2% of inTEST shares are owned by institutional investors. 6.9% of Quanterix shares are owned by company insiders. Comparatively, 5.5% of inTEST shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

inTEST beats Quanterix on 10 of the 19 factors compared between the two stocks.